Back to Search Start Over

Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation.

Authors :
Amayiri N
Al-Hussaini M
Swaidan M
Jaradat I
Qandeel M
Tabori U
Hawkins C
Musharbash A
Alsaad K
Bouffet E
Source :
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery [Childs Nerv Syst] 2016 Mar; Vol. 32 (3), pp. 553-7. Date of Electronic Publication: 2015 Aug 21.
Publication Year :
2016

Abstract

Synchronous primary malignant brain tumors are rare. We present a 5-year-old boy with synchronous glioblastoma and medulloblastoma. Both tumor samples had positive p53 stain and loss of PMS2 and MLH1 stains. The child had multiple café au lait spots and a significant family history of cancer. After subtotal resection of both tumors, he received craniospinal radiation with concomitant temozolomide followed by chemotherapy, alternating cycles of cisplatin/lomustine/vincristine with temozolomide. Then, he started maintenance treatment with cis-retinoic acid (100 mg/m(2)/day for 21 days). He remained asymptomatic for 34 months despite a follow-up brain MRI consistent with glioblastoma relapse 9 months before his death. Cis-retinoic acid may have contributed to prolong survival in this child with a probable biallelic mismatch repair syndrome.

Details

Language :
English
ISSN :
1433-0350
Volume :
32
Issue :
3
Database :
MEDLINE
Journal :
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Publication Type :
Academic Journal
Accession number :
26293676
Full Text :
https://doi.org/10.1007/s00381-015-2883-3